UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040945
Receipt number R000046750
Scientific Title The Efficacy of Safe and Sound Protocol on auditory hypersensitivity and communication deficits in children with autism spectrum disorder
Date of disclosure of the study information 2020/07/14
Last modified on 2022/07/04 14:09:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Efficacy of Listening therapy on auditory hypersensitivity and communication deficits in children with autism spectrum disorder

Acronym

The Efficacy of Listening therapy on auditory hypersensitivity and communication deficits in children with autism spectrum disorder

Scientific Title

The Efficacy of Safe and Sound Protocol on auditory hypersensitivity and communication deficits in children with autism spectrum disorder

Scientific Title:Acronym

The Efficacy of Safe and Sound Protocol on auditory hypersensitivity and communication deficits in children with autism spectrum disorder

Region

Japan


Condition

Condition

Autism Spectrum Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine the efficacy of Safe and Sound Protocol on children with Autism Spectrum Diorder

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

SRS-2:The second edition of the widely administered Social Responsiveness Scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Using Safe and Sound Protocol 1 hour/day for 5 days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Diagnosed as Autism Spectrum Disorder using ADOS-2 and ADI-R by research team
2.Who haven't experienced Listening therapy
3.Patients whose Legal representative fully understood the explanations and give their consent of their own free will to receive treatment

Key exclusion criteria

1) Patients with a serious physical disease or motor disfunction
2) Patients with a hereditary disease
3) Patients with a history of epilepsty

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Makiko
Middle name
Last name Kishimoto

Organization

National Center for Child Health and Development

Division name

Department of Pyschosical Medicine Divison of Early Childhood Mental Health

Zip code

157-8535

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535

TEL

0334160181

Email

kishimoto-m@ncchd.go.jp


Public contact

Name of contact person

1st name Makiko
Middle name
Last name Kishimoto

Organization

National Center for Child Health and Development

Division name

Department of Pyschosical Medicine Divison of Early Childhood Mental Health

Zip code

157-8535

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535

TEL

0334160181

Homepage URL


Email

kishimoto-m@ncchd.go.jp


Sponsor or person

Institute

National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

National Center for Child Health and Development

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Child Health and Development

Address

2-10-1 Okura, Setagaya, Tokyo 157-8535

Tel

0334160181

Email

kishimoto-m@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 29 Day

Date of IRB

2020 Year 07 Month 15 Day

Anticipated trial start date

2020 Year 07 Month 30 Day

Last follow-up date

2022 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 29 Day

Last modified on

2022 Year 07 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046750


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name